toxic epidermal necrolysis
Showing 1 - 9 of 9
Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)
Recruiting
- Toxic Epidermal Necrolysis
-
Fuzhou, Fujian, ChinaDepartment of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023
Epidermal Necrolysis, Lyell Syndrome, Toxic Epidermal Necrolysis Trial (Adipose derived stromal cells intravenously injected)
Not yet recruiting
- Epidermal Necrolysis
- +5 more
- Adipose derived stromal cells intravenously injected
- (no location specified)
Sep 27, 2021
Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Unknown status
- Stevens-Johnson Syndrome
- +2 more
- Site specific standard of care comparison
- (no location specified)
Dec 1, 2020
Toxic Epidermal Necrolysis Trial in Sacramento (Clobetasol 0.05% ointment, Placebo)
Withdrawn
- Toxic Epidermal Necrolysis
- Clobetasol 0.05% ointment
- Placebo
-
Sacramento, CaliforniaUniversity of California, Davis Department of Dermatology
Aug 7, 2019
Steven-Johnson Syndrome, Toxic Epidermal Necrolysis, Drug Reaction With Eosinophilia and Systemic Symptoms Trial in Bangkok
Unknown status
- Steven-Johnson Syndrome
- +4 more
-
Bangkok, ThailandFaculty of Medicine, Chulalongkorn University
Feb 15, 2019
Toxic Epidermal Necrolysis Trial in Boston (Isotretinoin, Placebo)
Unknown status
- Toxic Epidermal Necrolysis
- Isotretinoin
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Dec 5, 2016
Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome Trial in Bridgeport, New Haven (Palifermin)
Terminated
- Toxic Epidermal Necrolysis
- Stevens-Johnson Syndrome
-
Bridgeport, Connecticut
- +1 more
Oct 6, 2016
Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis Trial in Tokyo (Intravenous immunoglobulin)
Completed
- Stevens-Johnson Syndrome
- Toxic Epidermal Necrolysis
- Intravenous immunoglobulin
-
Tokyo, JapanNihon Pharmaceutical Co., Ltd
Jul 1, 2014
Toxic Epidermal Necrolysis Trial (Remicaide (infliximab))
Withdrawn
- Toxic Epidermal Necrolysis
- Remicaide (infliximab)
- (no location specified)
Apr 25, 2013